According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is $3.58 Million USD. In 2022 the company made a revenue of -$32.13 Million USD a decrease over the revenue in the year 2021 that were of $13.81 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.